Goldline Pharmaceutical Ltd PE Ratio

Goldline Pharmaceutical PE Ratio

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

PE

-

Last updated on: May 20, 2026

Key Highlights

  • The P/E Ratio of Goldline Pharmaceutical Ltd is 0 as of 20 May 26 The P/E Ratio of Goldline Pharmaceutical Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years The Latest Trading Price of Goldline Pharmaceutical Ltd is ₹ 53.94 as of 20 May 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.3 in 5 years. This represents a CAGR of 5.60% The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 20.0. The PE Ratio of IT - Software industry is 17.9. The PE Ratio of Pharmaceuticals industry is 32.3. The PE Ratio of Retail industry is 123.7. The PE Ratio of Textiles industry is 53.9 in 2025 .

Historical P/E Ratio of Goldline Pharmaceutical Ltd

No data available

Company Fundamentals for Goldline Pharmaceutical Ltd

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

Share Price

₹ 53.94

-2.83 (-4.99%)

stock direction

Last updated on: May 20, 2026

Market Price of Goldline Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Goldline Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 May 202653.94
19 May 202656.77

BlinkX Score for Goldline Pharmaceutical Ltd

Asset Value vs Market Value of Goldline Pharmaceutical Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Goldline Pharmaceutical Ltd Explained

51.78

Market cap

2

Earnings

0.0X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Goldline Pharmaceutical Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Goldline Pharmaceutical Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Goldline Pharmaceutical Ltd

No data available

* All values are in %

About Goldline Pharmaceutical Ltd

  • Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
  • Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
  • September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
  • Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
  • The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.

Goldline Pharmaceutical Ltd News Hub

BSE SME Goldline Pharmaceutical delivers a dose of listing gains

The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc

Read more

19 May 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions